A new program guide, published by the Centers for Disease Control and Prevention (CDC), features the Maryland Patients, Pharmacists, Partnerships (P3) as an effective model of how health care teams that include pharmacists can improve the outcomes of patients with chronic diseases. P3 is a project initiated at the University of Maryland School of Pharmacy.
The CDC guide, Partnering with Pharmacists in the Prevention and Control of Chronic Diseases, encourages health care providers and organizations to build relationships with pharmacists.
"Physicians and pharmacists are joining forces through a number of collaborations between some of the nation's largest physician groups and retail drugstore chains," states the CDC guide. It highlights the Maryland project as a national example of how pharmacists can partner with other health care professionals to make a difference in patient care, "Similarly, Maryland's P3 Program has demonstrated an effective collaboration between the Maryland Department of Health and Mental Hygiene, the University of Maryland School of Pharmacy, the Mid-Atlantic and Virginia Business Groups on Health, the Maryland Pharmacists Association, and the Maryland General Assembly."
Magaly Rodriguez de Bittner, PharmD, CDE, FAPhA, professor and chair of the Department of Pharmacy Practice and Science and director of the Maryland P3 Program, says, "Receiving this recognition from the CDC underscores how the School of Pharmacy, the state of Maryland, the Maryland Pharmacists Association, and the Maryland P3 Program continue to shape the scope of pharmacy practice locally and nationally through the incorporation of pharmacists in the health care team."
She continues, "Our practitioners continue to pioneer new roles for pharmacists in advanced clinical practice and remain committed to a continued partnership with community, institutional, and long-term care pharmacies throughout the state and nation."
Acknowledging pharmacists as experts in the use of medications to optimize patient drug therapy, the CDC notes that these practitioners are also the most accessible members of the health care team. They provide direct patient care to ensure that medications are used in a safe and effective manner.
To illustrate the wide range of patient care services that pharmacists can provide, the guide refers to the Maryland P3 Program as an example of how pharmacists can partner with other health care providers and organizations to offer comprehensive medication management to improve chronic disease-related health outcomes.
The program, which uses trained pharmacists to assist patients with proper use of medications, diagnostic testing, counseling, and overall disease management, was highlighted for its work supporting pharmacists' collaboration with other health care providers to improve medication adherence and clinical and economic outcomes.
Though there are a number of programs across the United States designed to encourage health care providers and organizations to develop relationships with pharmacists, the CDC only featured two such programs in its guide, including the Maryland P3 Program.
"By becoming active participants in chronic disease management through team-based care, pharmacists in the Maryland P3 Program are proactively working to change pharmacy practice and advocate for payment reform," says Rodriguez de Bittner, who also served as a contributor to the CDC guide. "This innovative program has taken root and grown throughout the state and beyond because it enhances the continuity of care in the health systems in which it operates and provides data that supports the value of the pharmacist on the team."
University of Maryland School of Pharmacy